Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | CD38 | P28907 | 1/20 | 0.61 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | TERT | O14746 | 4/20 | 0.61 |
| ▸ | ATP1A1 | P05023 | 3/20 | 0.61 |
| ▸ | ATP1B1 | P05026 | 3/20 | 0.61 |
| ▸ | ATP1A3 | P13637 | 3/20 | 0.61 |
| ▸ | ATP1B2 | P14415 | 3/20 | 0.61 |
| ▸ | ATP1A2 | P50993 | 3/20 | 0.61 |
| ▸ | ATP1B3 | P54709 | 3/20 | 0.61 |
| ▸ | FXYD2 | P54710 | 3/20 | 0.61 |
| ▸ | ATP1A4 | Q13733 | 3/20 | 0.61 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.61 |
| ▸ | APP | P05067 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34972 | 0.89 | TERT (0.76) | MEN1KMT2ARECQLCD38TERT | |
| SCHEMBL31682973 | 0.89 | TERT (0.76) | MEN1KMT2ARECQLCD38TERT | |
| SCHEMBL4909482 | 0.84 | FBP1 (0.61) | MEN1KMT2ARECQLCD38ABCC1 | |
| SCHEMBL31438664 | 0.84 | ABCG2 (0.68) | MEN1KMT2ARECQLTERTATP1A1 | |
| SCHEMBL5569925 | 0.84 | ABCG2 (0.68) | MEN1KMT2ARECQLTERTATP1A1 | |
| SCHEMBL29904505 | 0.84 | FBP1 (0.61) | MEN1KMT2ARECQLCD38ABCC1 | |
| SCHEMBL2987776 | 0.81 | ATP1A1 (0.61) | MEN1KMT2ARECQLCD38ABCC1 | |
| SCHEMBL34929 | 0.81 | APP (0.67) | MEN1KMT2ATERTAPPKDM4E | |
| SCHEMBL29890070 | 0.79 | ATP1A1 (0.54) | MEN1KMT2ARECQLTERTATP1A1 | |
| SCHEMBL1880963 | 0.79 | MEN1 (0.66) | MEN1KMT2ARECQLCD38ABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935714-B2 | Compositions for sleeping disorders | Bright Future Pharmaceutical Laboratories (HK) | 2011-05-03 | — | — | US | disclosed |
| US-7935714-B2 | Compositions for sleeping disorders | Bright Future Pharmaceutical Laboratories (HK) | 2011-05-03 | — | — | US | disclosed |
| US-20090124627-A1 | COMPOSITIONS FOR SLEEPING DISORDERS | CHAN HSIAO CHANG | 2009-05-14 | — | — | US | disclosed |
| US-20090124627-A1 | COMPOSITIONS FOR SLEEPING DISORDERS | CHAN HSIAO CHANG | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124627-A1 | COMPOSITIONS FOR SLEEPING DISORDERS | PER2, CRY1, CRY2 | MEN1 4015/4885KMT2A 353/4885RECQL 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.